Vitrafy Life Sciences Limited (ASX:VFY)
Australia flag Australia · Delayed Price · Currency is AUD
1.730
+0.050 (2.98%)
At close: Apr 1, 2026

Vitrafy Life Sciences Revenue

Vitrafy Life Sciences had revenue of 1.98M AUD in the half year ending December 31, 2025, with 64.59% growth. This brings the company's revenue in the last twelve months to 2.34M, up 51.87% year-over-year. In the fiscal year ending June 30, 2025, Vitrafy Life Sciences had annual revenue of 1.05M, down -49.14%.

Revenue (ttm)
2.34M
Revenue Growth
+51.87%
P/S Ratio
47.14
Revenue / Employee
n/a
Employees
n/a
Market Cap
110.46M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Jun 30, 20251.05M-1.01M-49.14%
Jun 30, 20242.06M3.53K0.17%
Jun 30, 20232.06M230.64K12.63%
Jun 30, 20221.83M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition